FDA struggles to remain independent amid race for virus cure

FDA struggles to remain independent amid race for virus cure-politico: Peter Marks was a natural fit for a new White House project tasked with developing a coronavirus vaccine. The cancer specialist spent nearly a decade at the Food and Drug Administration, most recently overseeing the office that approves vaccines and gene therapies.